The Landscape of Bispecific Antibody Clinical Trials for Solid Tumors (2001–2025): Insights from ClinicalTrials.gov
Biologics: Targets and Therapy · 2026-11 · Volume 20 · 1-7
DOI: 10.2147/btt.s649375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biologics: Targets and Therapy, 2026-11. Verfasst von Wenjuan Wei und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wei, W., Wu, X., Zhang, J., Sun, J., Liu, P., Wang, L., & Wang, D. (2026). The Landscape of Bispecific Antibody Clinical Trials for Solid Tumors (2001–2025): Insights from ClinicalTrials.gov. Biologics: Targets and Therapy, Volume 20, 1-7. https://doi.org/10.2147/btt.s649375
Vancouver
Wei W, Wu X, Zhang J, Sun J, Liu P, Wang L, et al. The Landscape of Bispecific Antibody Clinical Trials for Solid Tumors (2001–2025): Insights from ClinicalTrials.gov. Biologics: Targets and Therapy. 2026;Volume 20:1-7. doi:10.2147/btt.s649375
BibTeX
@article{Wei2026,
author = {Wei, Wenjuan and Wu, Ximeng and Zhang, Jianing and Sun, Jian and Liu, Pengbo and Wang, Lizhi and Wang, Daqing},
title = {The Landscape of Bispecific Antibody Clinical Trials for Solid Tumors (2001–2025): Insights from ClinicalTrials.gov},
journal = {Biologics: Targets and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--7},
doi = {10.2147/btt.s649375}
}
EUVIMED